Marsi Bionics

Name

Marsi Bionics

Legal name

MARSI BIONICS S.L

Website

https://marsibionics.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Exoskeletons & Rehabilitation Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Pediatric Rehabilitation & Mobility DME (Adaptive Seating, Pediatric Mobility) (HLAHAMAI)

akta.pro secondary industries

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Healthcare & Assistive Robotics (HDAAAIAC), Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)

Keywords

• Pediatric exoskeletons
• Gait rehabilitation
• Robotic orthoses
• Neurorehabilitation devices
• Medical exoskeleton technology

Headquarters

HQ city

Vaciamadrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Marsi Bionics generates revenue through the sale of robotic medical exoskeleton devices including Atlas 2030 pediatric exoskeleton, EXPLORER MB personal exoskeleton, and MB-Active Knee robotic orthosis to hospitals, rehabilitation centers, and healthcare providers.
2. Clinical Therapy Services: Marsi Care platform provides robot-assisted research and therapy services for neurological diseases. The public-private collaboration between CSIC and Marsi Bionics offers patients access to cutting-edge therapies and participates in clinical research programs.
3. International Distribution: Revenue generated through authorized distributors including Medimex (France), Skyfi (Poland), and Rehagirona (Spain) who resell and distribute Marsi Bionics products in their respective territories.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Marsi Bionics develops and manufactures self-adaptive gait exoskeletons and robotic orthoses for clinical rehabilitation and mobility assistance, built on its proprietary ARES (Actively Responsive Exoskeleton System) technology with variable-stiffness active joints. The company sells the Atlas 2030 pediatric exoskeleton, the EXPLORER MB personal-use pediatric exoskeleton, the MB-Active Knee robotic knee orthosis, and operates the Marsi Care clinical therapy platform in collaboration with CSIC. Devices are targeted at hospitals, rehabilitation centers, and pediatric neurorehabilitation institutions treating patients with cerebral palsy, spinal muscular atrophy, stroke, and post-surgical knee conditions.

Product overview

Marsi Bionics develops innovative gait exoskeleton technology based on proprietary ARES technology with active joints and variable stiffness that mimics natural muscle function. The product portfolio consists of three core devices: Atlas 2030 (pediatric exoskeleton for clinical rehabilitation of children with neuromuscular conditions), EXPLORER MB (first pediatric exoskeleton for personal/home use for children with neurodevelopmental disorders aged 2-17), and MAK Active Knee (robotic knee orthosis for adult rehabilitation after surgery or stroke). The company also operates Marsi Care, a clinical research and therapy platform for robot-assisted neurorehabilitation. The products are designed for rehabilitation of a wide range of neurological conditions affecting over 40 million patients worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Atlas 2030: Pediatric exoskeleton designed to assist children with neuromuscular conditions in walking and rehabilitation therapy.
• EXPLORER MB
• MB-Active Knee
• Marsi Care

Products and services

• Atlas 2030 Pediatric Exoskeleton

Quantifiable outcome

• Improvement in gross motor function in children with cerebral palsy after rehabilitation with Atlas 2030
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered flagship and minor.

• CSIC (Spanish National Research Council)flagshipStrategic or Co-development Partner · 1 January 2023Public-private collaboration between CSIC and Marsi Bionics established the Marsi Care platform for robot-assisted research and therapy. CSIC provides research expertise and institutional credibility through the Centre for Automation and Robotics (CSIC-UPM).
• RehakindminorOthers · 1 January 2023Marsi Bionics is listed as a member of Rehakind organization, indicating participation in a pediatric rehabilitation industry network.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hocoma: Hocoma (Switzerland) is a leading provider of robotic and sensor-based medical devices for rehabilitation, including the Lokomat gait trainer and Armeo products. It is a direct competitor in hospital-based robotic gait rehabilitation, often sold into the same pediatric and adult rehabilitation centers that Marsi Bionics targets.
• Wandercraft: Wandercraft is a French robotics company developing self-balancing Atalante personal and clinical exoskeletons for patients with mobility impairments. As a European peer with similar ARES-comparable technology and gait rehabilitation focus, it is a close direct competitor in the same geographies as Marsi Bionics.
• Cyberdyne: Cyberdyne (Japan) produces the HAL (Hybrid Assistive Limb) robotic exoskeleton for medical and welfare applications. It is a direct competitor in the medical exoskeleton space with established hospital deployments, particularly in Asia, and shares Marsi Bionics' gait rehabilitation focus.
• Ekso Bionics: Ekso Bionics is a publicly listed developer of exoskeletons for medical and industrial use. It is the most direct competitor to Marsi Bionics in the rehabilitation exoskeleton category, with overlapping hospital customers and similar robotic gait-assist devices (e.g., EksoNR for stroke and spinal cord injury).
• Parker Hannifin (Indego): Parker Hannifin's Indego is a powered exoskeleton for individuals with spinal cord injury, marketed through Vanderbilt license. It competes directly with Marsi Bionics in the clinical gait rehabilitation exoskeleton segment, with FDA-cleared and CE-marked devices distributed through hospital networks.
• ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for spinal cord injury and stroke rehabilitation, with FDA-cleared personal and rehabilitation systems. It competes head-on with Marsi Bionics in the gait rehabilitation exoskeleton category for clinical use.
• Rex Bionics: Rex Bionics (New Zealand) produces the REX robotic exoskeleton for people with mobility impairments. While it focuses more on self-supporting standing and walking rather than gait training, it competes with Marsi Bionics in the powered clinical exoskeleton category for rehabilitation and mobility assistance.

Emerging players

• Bionik Laboratories: Bionik Laboratories develops robotic rehabilitation devices for stroke and other neurological conditions, including the InMotion ARM and InMotion ANKLE systems. It is a smaller emerging player in rehabilitation robotics with partial overlap to Marsi Bionics' clinical rehabilitation focus.
• Tyromotion: Tyromotion (Austria) develops robotic-assisted therapy devices for upper extremity and gait rehabilitation, including the OMEGO and LEXO systems. It is an emerging European peer with partial overlap to Marsi Bionics' pediatric and adult rehabilitation focus.

Others

• CSIC (Spanish National Research Council) - Centre for Automation and Robotics: CSIC's Centre for Automation and Robotics is the public research institution from which Marsi Bionics was spun off in 2013 and continues to collaborate through the Marsi Care platform. It is an enabling research partner rather than a competitor, providing foundational IP, clinical collaboration, and institutional credibility.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/marsibionics
• Facebookfacebook.com/marsibionics

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds6 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marsi Bionics